Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 108 in rheumatoid arthritis with methotrexate
2005-003558-83Phase 2Completed
- Sponsor
- Amgen
- Start
- Jan 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing AMG 108 + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: ACR20 response at Week 16. Started Jan 2006; status: completed.
02
Drugs
AMG 108
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2005-003558-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003558-83.